Status:
COMPLETED
US-Doppler and Procoagulant Microparticles for the Diagnosis of Asymptomatic DVT in Advanced Cancer Patients With Poor Performance Status
Lead Sponsor:
Rambam Health Care Campus
Conditions:
Deep Vein Thrombosis
Cancer
Eligibility:
All Genders
18+ years
Brief Summary
The aim of this study is to determine the prevalence of asymptomatic lower extremity DVT detected by US-Doppler and procoagulant microparticles in a selected group of cancer patients suffering from an...
Detailed Description
The association between malignancy and venous thromboembolism(VTE) is well known. VTE is one of the most common complications seen in cancer patients Early detection of VTE can identify patients who m...
Eligibility Criteria
Inclusion
- Cancer patients with an advanced stage of the disease, hospitalized in the oncology department.
- WHO performance status of 3( i.e. spends more than half his/her time in bed or seated) - or 4 ( i.e. completely confined to bed or to chair) : for at least a week; according to the treating physician, the poor performance status results from advanced malignancy.
- Patient is asymptomatic for lower extremity DVT according to the treating physician
Exclusion
- major surgery during more than a month, from the time of investigation
- anticoagulant therapy for more than one month, from the time of investigation
Key Trial Info
Start Date :
June 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2010
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00336258
Start Date
June 1 2006
End Date
December 1 2010
Last Update
December 14 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rambam medical center
Haifa, Israel